Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
TILT TESTING EVOLVES: FASTER AND STILL ACCURATE coverClinical reviewsTILT TESTING EVOLVES: FASTER AND STILL ACCURATEKarolinska University Hospital, Karolinska Institute, Lund University, Libin Cardiovascular Institute, University of Calgary, National Heart & Lung Institute·Cardiology· 3 pagesThis editorial discusses the evolution of the tilt test protocol for reflex syncope and autonomic dysfunction, highlighting the Fast Italian protocol's potential to streamline care.
INTERNATIONAL CONSENSUS ON STANDARDIZED CLINIC BLOOD PRESSURE MEASUREMENT — A CALL TO ACTION coverGuidelines & protocolsINTERNATIONAL CONSENSUS ON STANDARDIZED CLINIC BLOOD PRESSURE MEASUREMENT — A CALL TO ACTIONUniversity of Utah Health, Tulane University School of Public Health and Tropical Medicine, University of Alabama at Birmingham, University of New South Wales, Columbia University Irving Medical Center, University College London, and others·Cardiology· 9 pagesThis document presents a consensus on the standardized measurement of blood pressure in clinical settings, emphasizing the importance of accurate and consistent practices to improve patient outcomes.
SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence coverClinical reviewsSGLT-2 Inhibitors in Heart Failure: A Review of Current EvidenceUniversity of Mississippi Medical Center, Charité Universitätsmedizin Berlin, Baylor Scott and White Research Institute·Cardiology· 2023· 9 pagesThis review discusses the role of SGLT-2 inhibitors in the management of heart failure, highlighting their impact on cardiovascular outcomes across different ejection fraction categories.
DIAGNOSIS AND TREATMENT OF ACUTE MYOCARDITIS coverClinical reviewsDIAGNOSIS AND TREATMENT OF ACUTE MYOCARDITISnull·Cardiology· 2023· 16 pagesThis document provides a comprehensive review of acute myocarditis, including its causes, symptoms, diagnostic methods, and treatment options.
A REVIEW OF CURRENT KEY GUIDELINES FOR MANAGING HIGH RISK PATIENTS WITH DIABETES AND HEART FAILURE coverClinical reviewsA REVIEW OF CURRENT KEY GUIDELINES FOR MANAGING HIGH RISK PATIENTS WITH DIABETES AND HEART FAILURESchool of Cardiovascular and Metabolic Health, BHF Glasgow Cardiovascular Research Centre, University of Glasgow·Cardiology· 23 pagesThis document reviews recent guidelines on the management of heart failure in patients with diabetes, focusing on major recommendations from European and USA society guidelines.
RENIN-ANGIOTENSIN INHIBITION AND OUTCOMES IN HFrEF AND ADVANCED KIDNEY DISEASE coverClinical reviewsRENIN-ANGIOTENSIN INHIBITION AND OUTCOMES IN HFrEF AND ADVANCED KIDNEY DISEASEThe American Journal of Medicine·Cardiology· 2023· 24 pagesThis article investigates the effects of renin-angiotensin system inhibition on clinical outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and advanced kidney disease.
SUBCLINICAL LEAFLET THROMBOSIS AND ANTICOAGULATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT coverClinical reviewsSUBCLINICAL LEAFLET THROMBOSIS AND ANTICOAGULATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENTNew York–Presbyterian Hospital/Columbia University Irving Medical Center·Cardiology· 2022· 7 pagesThis review discusses the prevalence and management of subclinical leaflet thrombosis in patients after transcatheter aortic valve replacement (TAVR), highlighting the role of oral anticoagulation.
PULMONARY HYPERTENSION ASSOCIATED WITH LEFT HEART DISEASE coverClinical reviewsPULMONARY HYPERTENSION ASSOCIATED WITH LEFT HEART DISEASEClinic III for Internal Medicine (Dept. of Cardiology, Pulmonology, and Intensive Care Medicine), Cologne Cardiovascular Research Center (CCRC), Heart Center at the University Hospital Cologne, Center for Molecular Medicine Cologne (CMMC), Faculty of·Cardiology· 2023· 8 pagesThis document reviews the complexities of pulmonary hypertension (PH) in patients with left heart disease (LHD), focusing on updated hemodynamic definitions and management strategies.
THE UTILITY OF INVASIVE HEMODYNAMICS IN THE MANAGEMENT OF CARDIOGENIC SHOCK coverClinical reviewsTHE UTILITY OF INVASIVE HEMODYNAMICS IN THE MANAGEMENT OF CARDIOGENIC SHOCKWestern University, London Health Sciences Centre, London, Ontario, Canada·Cardiology· 2023· 3 pagesThis article discusses the role of pulmonary artery catheters (PACs) in the management of cardiogenic shock, highlighting their potential benefits and the variability of their use in Canada.
SARCOPENIA AND CARDIOVASCULAR DISEASES coverClinical reviewsSARCOPENIA AND CARDIOVASCULAR DISEASESInova Heart and Vascular Institute; Johns Hopkins University School of Medicine; Cleveland Clinic; University of Arizona; University of Connecticut; Weill Cornell Medicine; University of Washington; University of Texas; University of Pittsburgh; Kaiser·Cardiology· 20 pagesThis document discusses the relationship between sarcopenia, characterized by the loss of muscle strength and mass, and cardiovascular diseases, highlighting the increased risks associated with these conditions, particularly in older adults.
COMPARATIVE EFFECTIVENESS OF ASPIRIN DOSING IN CARDIOVASCULAR DISEASE coverClinical reviewsCOMPARATIVE EFFECTIVENESS OF ASPIRIN DOSING IN CARDIOVASCULAR DISEASEThe New England Journal of Medicine·Cardiology· 2021· 10 pagesThis study investigates the appropriate dose of aspirin to lower the risk of death, myocardial infarction, and stroke while minimizing major bleeding in patients with established atherosclerotic cardiovascular disease.
ANTIPLATELET AGENTS IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION coverClinical reviewsANTIPLATELET AGENTS IN ACUTE ST ELEVATION MYOCARDIAL INFARCTIONOregon Health and Science University, Portland, Ore.·Cardiology· 2022· 12 pagesThis article reviews the mechanisms, pharmacokinetics, and key clinical trials related to platelet inhibitors used in the management of ST elevation myocardial infarction (STEMI). It highlights the role of platelet aggregation in acute coronary syndrome and discusses current recommendations from the American College of Cardiology/American Heart Association.
SARCOPENIA AND CARDIOVASCULAR DISEASES coverClinical reviewsSARCOPENIA AND CARDIOVASCULAR DISEASESInova Heart and Vascular Institute; Johns Hopkins University School of Medicine; Cleveland Clinic; University of Arizona; University of Connecticut; Weill Cornell Medicine; University of Washington; University of Texas; University of Pittsburgh;·Cardiology· 20 pagesThis document discusses the relationship between sarcopenia, characterized by loss of muscle strength and mass, and various cardiovascular diseases. It highlights the implications of sarcopenia on patient outcomes, particularly in older adults.
MANAGEMENT OF ACUTE CORONARY SYNDROME coverGuidelines & protocolsMANAGEMENT OF ACUTE CORONARY SYNDROMEJoel Atwood, MD·Cardiology· 14 pagesThis document provides a comprehensive overview of the management strategies for acute coronary syndrome (ACS), focusing on ST-segment elevation myocardial infarction (STEMI) and its clinical implications.
WORSENING OF CHRONIC HEART FAILURE: DEFINITION, EPIDEMIOLOGY, MANAGEMENT AND PREVENTION coverClinical reviewsWORSENING OF CHRONIC HEART FAILURE: DEFINITION, EPIDEMIOLOGY, MANAGEMENT AND PREVENTIONHeart Failure Association of the European Society of Cardiology·Cardiology· 2023· 16 pagesThis position paper provides a clinical consensus statement on the definition, epidemiology, management, and prevention of worsening chronic heart failure.
ANGIOTENSIN RECEPTOR – NEPRILYSIN INHIBITORS FOR HYPERTENSION — HEMODYNAMIC EFFECTS AND RELEVANCE TO HYPERTENSIVE HEART DISEASE coverClinical reviewsANGIOTENSIN RECEPTOR – NEPRILYSIN INHIBITORS FOR HYPERTENSION — HEMODYNAMIC EFFECTS AND RELEVANCE TO HYPERTENSIVE HEART DISEASEMedical University·Cardiology· 2022· 14 pagesThis review article discusses the beneficial effects of angiotensin receptor – neprilysin inhibitors on the cardiovascular system, particularly their role in managing hypertension and hypertensive heart disease.
OUTCOMES OF DIGOXIN VS. BETA BLOCKER IN ATRIAL FIBRILLATION: REPORT FROM ESC–EHRA EORP AF LONG-TERM GENERAL REGISTRY coverClinical reviewsOUTCOMES OF DIGOXIN VS. BETA BLOCKER IN ATRIAL FIBRILLATION: REPORT FROM ESC–EHRA EORP AF LONG-TERM GENERAL REGISTRYUniversity of Belgrade, Universitaire Trousseau, University of Modena and Reggio Emilia, University of Murcia, University of Liverpool, Clinical Center of Serbia, Aalborg University, Uppsala University·Cardiology· 2022· 11 pagesThis study evaluates the safety and effects of digoxin compared to beta-blocker therapy in patients with atrial fibrillation (AF). It aims to clarify the associated risks of digoxin therapy, particularly concerning mortality and quality of life.
RIGHT VENTRICULAR DIASTOLIC DYSFUNCTION AND FAILURE: A REVIEW coverClinical reviewsRIGHT VENTRICULAR DIASTOLIC DYSFUNCTION AND FAILURE: A REVIEWYoun-Hoa Jung, Xianfeng Ren, Giancarlo Suffredini, Jeffery M. Dodd-o, Wei Dong Gao·Cardiology· 2021· 14 pagesThis review discusses right ventricular diastolic dysfunction and failure (RVDDF), highlighting its association with various cardiovascular diseases and its implications for clinical management.
ATRIAL FIBRILLATION: OVERVIEW OF MANAGEMENT coverClinical reviewsATRIAL FIBRILLATION: OVERVIEW OF MANAGEMENTKapil Kumar, MD·Cardiology· 2026· 48 pagesThis document provides a comprehensive overview of the management of atrial fibrillation (AF), the most commonly treated cardiac arrhythmia, focusing on both initial and long-term management strategies.
GUIDELINE WATCH ROUNDUP coverClinical reviewsGUIDELINE WATCH ROUNDUPBrigham and Women's Hospital·Cardiology· 2026· 27 pagesSummaries and highlights of the most important new clinical guidelines to inform your practice.
EPIDEMIOLOGY, RISK FACTORS, AND PREVENTION OF ATRIAL FIBRILLATION coverClinical reviewsEPIDEMIOLOGY, RISK FACTORS, AND PREVENTION OF ATRIAL FIBRILLATIONUpToDate, Inc.·Cardiology· 2026· 34 pagesThis document provides an overview of the epidemiology, risk factors, and prevention strategies related to atrial fibrillation.
CARDIAC IMPLANTABLE ELECTRONIC DEVICE-INDUCED TRICUSPID REGURGITATION: IMPLICATIONS AND MANAGEMENT coverClinical reviewsCARDIAC IMPLANTABLE ELECTRONIC DEVICE-INDUCED TRICUSPID REGURGITATION: IMPLICATIONS AND MANAGEMENTMassachusetts General Hospital, Boston, Massachusetts, USA·Cardiology· 2024· 9 pagesThis document discusses tricuspid regurgitation (TR) secondary to cardiac implantable electronic devices (CIEDs), highlighting its implications and management strategies.
GLUCAGON-LIKE PEPTIDE-1-BASED THERAPIES IN CARDIOVASCULAR DISEASE: EVIDENCE, MECHANISMS, AND EMERGING CLINICAL APPLICATIONS coverClinical reviewsGLUCAGON-LIKE PEPTIDE-1-BASED THERAPIES IN CARDIOVASCULAR DISEASE: EVIDENCE, MECHANISMS, AND EMERGING CLINICAL APPLICATIONSDivision of Cardiology, Azienda Ospedaliero-Universitaria Policlinico 'G. Rodolico-San Marco', University of Catania·Cardiology· 2026· 16 pagesThis document reviews the cardiovascular effects of glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes, and their emerging role in cardiometabolic health.
ATRIAL FIBRILLATION IN ADULTS: RATE CONTROL IN PATIENTS WITHOUT HEART FAILURE coverClinical reviewsATRIAL FIBRILLATION IN ADULTS: RATE CONTROL IN PATIENTS WITHOUT HEART FAILURERachel Kaplan, MD, MS·Cardiology· 2025· 39 pagesThis document reviews pharmacologic therapies for achieving rate control in patients with atrial fibrillation who do not have heart failure, detailing the mechanisms and evidence surrounding various treatment options.
PreviousPage 14 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount